Pre-market data show Naked Brand Group Limited (NASDAQ:NAKD) is -2.44% lower at $0.1561. It recently closed at $0.16, fluctuating in a day’s range from $0.1426 to $0.169 and a 52-week trading range of $0.07 to $3.70.
Zomedica Corp. (AMEX:ZOM) is trading at $0.1591 down with -2.15 percent or -0.0 point in pre-market trading today. It recently closed at $0.16, fluctuating in a day’s range from $0.15 to $0.17.
Aethlon Medical Inc. (NASDAQ:AEMD) shares traded over -7.08% lower in pre-market trading on Thursday after declaring that first patient treated in first-in-human clinical trial of HEMOPURIFIER® in head and neck cancer. The consensus recommendation for the company is Moderate Buy.
Shares of CureVac N.V. (CVAC) are -10.08% lower in pre-market trading this morning. The company recently declared that it has enrolled the first participant in the pivotal Phase 2b/3 study of its mRNA vaccine candidate, CVnCoV, against COVID-19. Credit Suisse issued an Underperform recommendation for CureVac N.V. with a target price of $47.
Qutoutiao Inc. (NASDAQ:QTT) was moving -5.6% lower in pre-market trading for Jefferies after reporting its unaudited financial results in the third quarter ended September 30, 2020. Alongside 1 buy ratings, QTT scores an average top analyst price target of $3.54.
InVivo Therapeutics Holdings Corp. (NVIV)’s shares, down -84.73% this year, were -5.63% lower in pre-market trading.
Pre-market data show Liquidia Corporation (NASDAQ:LQDA) is -7.87% lower at $2.81. The firm recently revealed that Damian deGoa has been appointed as Chief Executive Officer (CEO) and a director of the Company It last finished at $3.05, fluctuating in a day’s range from $2.92 to $3.095. Analysts believe the stock will be worth $5.20 within the next 12 to 18 months.
SG Blocks Inc. (NASDAQ:SGBX) is trading at $3.92 down with -1.01 percent or -0.04 point in pre-market trading today. It recently closed at $3.96, fluctuating in a day’s range from $3.75 to $4.3647.
Immutep Limited (NASDAQ:IMMP) shares traded over -3.9% lower in pre-market trading on Thursday after reporting that it has prioritised the recommencement of the process of scaling up the manufacturing of its lead product candidate eftilagimod alpha (“efti” or “IMP321”). B. Riley FBR has a Buy rating on the IMMP stock and set a $7.75 price target. The shares have a consensus Moderate Buy rating and a 52-week trading range of $0.53 to $7.95.
Shares of Uxin Limited (NASDAQ:UXIN) are -10.71% lower in pre-market trading this morning following the release of its unaudited financial results for the quarter ended September 30, 2020.
Code Chain New Continent Limited (NASDAQ:CCNC) was moving -5.49% lower in pre-market trading for Thursday, December 2020.
Moxian Inc. (NASDAQ:MOXC)’s shares, higher 5.16% over the week, were -4.15% lower in pre-market trading..